Part 2 of Schedule 1 to the Principal Act is amended as follows:
by inserting after item 74 the following:
| l-cyclohexyl-4-(1,2-diphenylethyl)piperazine (otherwise known as MT-45) | |
by inserting after item 81A the following:
| 3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide (otherwise known as U-47700) | |
by inserting after item 119 the following:
| Ethylnaphthidate (otherwise known as HDEP-28) | |
by omitting item 120A and substituting the following:
by omitting items 127A, 127B and 127C and substituting the following:
| 2-fluoromethcathinone | 25 grams (or 20 Units) |
| 3-fluoromethcathinone | 25 grams (or 20 Units) |
| 4-fluoromethcathinone | 25 grams (or 20 Units) |
by inserting after item 127D the following:
| 3-fluorophenmetrazine | |
| in individual packages | 20 packages |
| in any other form | 25g |
by inserting after item 183 the following:
| Methylnaphthidate (otherwise known as HDMP-28) | |
The amendments effected by this clause have been incorporated into the authorised version of the Misuse of Drugs Act 2001.